Faculty Opinions recommendation of SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.

2019 ◽  
Author(s):  
Wilbert Aronow
Keyword(s):  
Systematic Review ◽  
Type 2 Diabetes ◽  
Secondary Prevention ◽  
Meta Analysis ◽  
Sglt2 Inhibitors ◽  
Cardiovascular Outcome ◽  
Primary And Secondary Prevention ◽  
Cardiovascular Outcome Trials ◽  
Renal Outcomes

Type 2 diabetes and risk of heart failure: a systematic review and meta-analysis from cardiovascular outcome trials

Endocrine ◽  
2019 ◽  
Vol 65 (1) ◽  
pp. 15-24 ◽  
Author(s):  
Dario Giugliano ◽  
Maria Ida Maiorino ◽  
Miriam Longo ◽  
Giuseppe Bellastella ◽  
Paolo Chiodini ◽  
...  
Keyword(s):  
Heart Failure ◽  
Systematic Review ◽  
Type 2 Diabetes ◽  
Meta Analysis ◽  
Cardiovascular Outcome ◽  
Cardiovascular Outcome Trials

scholarly journals SGLT2 inhibitors and renal outcomes in type 2 diabetes with or without renal impairment: A systematic review and meta-analysis

2018 ◽  
Vol 12 (3) ◽  
pp. 265-283 ◽  
Author(s):  
Samuel Seidu ◽  
Setor K. Kunutsor ◽  
Xavier Cos ◽  
Syed Gillani ◽  
Kamlesh Khunti
Keyword(s):  
Systematic Review ◽  
Type 2 Diabetes ◽  
Renal Impairment ◽  
Meta Analysis ◽  
Sglt2 Inhibitors ◽  
Renal Outcomes
Sign in / Sign up

Export Citation Format

Share Document